Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer

Study ID: NCT07042919
Start Date: 2026-03-04
End Date: 2031-03-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

53

Intervention / Treatment

Biospecimen Collection

Computed Tomography

Echocardiography Test

Magnetic Resonance Imaging

Multigated Acquisition Scan

Zanzalintinib

Sponsor

Northwestern University

Source: clinicaltrials.gov

Share:
Add to list

The Effects of Orexin Antagonism on Fear Extinction in PTSD

Study ID: NCT06788522
Start Date: 2026-03-01
End Date: 2032-06-30
Study Type

Interventional

Study Phase

Phase4

No. of Participants

40120

Intervention / Treatment

Suvorexant

Placebo

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Effects of Latin Dancing on Sleep Quality in Hispanic Cancer Survivors

Study ID: NCT06844981
Start Date: 2026-04
End Date: 2027-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Latin Dance

Sponsor

Rutgers, The State University of New Jersey

Source: clinicaltrials.gov

Share:
Add to list

Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

Study ID: NCT07286058
Start Date: 2026-02-27
End Date: 2029-12-18
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1182

Intervention / Treatment

Zasocitinib

Sponsor

Takeda

Source: clinicaltrials.gov

Share:
Add to list

Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway

Study ID: NCT07175376
Start Date: 2026-05
End Date: 2027-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

32

Intervention / Treatment

Supportive Care

Sponsor

Wake Forest University Health Sciences

Source: clinicaltrials.gov

Share:
Add to list

EFFECT OF PLAZEPOD VERSUS ELECTRICAL STIMULATION ON RISK OF FALLING IN HEMODIALYSIS PATIENTS

Study ID: NCT07380191
Start Date: 2026-03-21
End Date: 2027-03-22
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Device + Behavioral

Neuromuscular Electrical Stimulation (NMES)

Sponsor

Cairo University

Source: clinicaltrials.gov

Share:
Add to list

GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Post-Market Clinical Follow-Up (PMCF) Observational Registry

Study ID: NCT07279649
Start Date: 2026-06
End Date: 2031-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

240

Intervention / Treatment

Reduced Profile GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (Reduced Profile VBX Stent Graft-BXB)

Sponsor

W.L.Gore & Associates

Source: clinicaltrials.gov

Share:
Add to list

The Agenda-Setting for Kidney Disease Open Pilot Trial

Study ID: NCT07221604
Start Date: 2026-07
End Date: 2026-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Chronic Kidney Disease Structured Agenda-Setting Tool

Sponsor

Dartmouth-Hitchcock Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Ketamine in Severe Traumatic Brain Injury

Study ID: NCT06062628
Start Date: 2026-06-01
End Date: 2027-06
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

10

Intervention / Treatment

Ketamine Hydrochloride

Sponsor

University of Texas Southwestern Medical Center

Source: clinicaltrials.gov

Share:
Add to list

BiFeS vs. iPACK in Postoperative Knee Arthroplasty Analgesia

Study ID: NCT07360392
Start Date: 2026-03-01
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

88

Intervention / Treatment

Biceps Femoris Short Head Block (BiFeS)

Infiltration Between The Popliteal Artery and The Capsule of The Knee

Adductor Canal Block

Sponsor

Amasya University

Source: clinicaltrials.gov

Share:
Add to list